Jaguar Health (JAGX) EBITDA Margin Growth (3y) (2018 - 2026)
Jaguar Health (JAGX) EBITDA Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Jaguar Health |
1.44 Mn |
-10.19 Mn |
19.11 Mn |
2.19 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
2.19 Mn |
| Dec 31, 2025 |
1.90 Mn |
| Sep 30, 2025 |
7,939.00 |
| Jun 30, 2025 |
-4,697.00 |
| Mar 31, 2025 |
5.83 Mn |
| Dec 31, 2024 |
27,443.00 |
| Sep 30, 2024 |
127,888.00 |
| Jun 30, 2024 |
279,091.00 |
| Mar 31, 2024 |
35,694.00 |
| Dec 31, 2023 |
-27,269.00 |
| Sep 30, 2023 |
-11,762.00 |
| Jun 30, 2023 |
6.01 Mn |
| Mar 31, 2023 |
63,399.00 |
| Dec 31, 2022 |
-1.93 Mn |
| Sep 30, 2022 |
37,721.00 |
| Jun 30, 2022 |
40,082.00 |
| Mar 31, 2022 |
-5.84 Mn |
| Dec 31, 2021 |
25,197.00 |
| Sep 30, 2021 |
-93,782.00 |
| Jun 30, 2021 |
-225,447.00 |
